OVERVIEW

Neurology: Hearing impairment in patients with myotonic dystrophy type 2 is organized by American Academy of Neurology (AAN) and will be held from Feb 13, 2018 - Feb 13, 2021.

Accrediation:
The American Academy of Neurology Institute designates this journal-based-CME activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Learning Objectives:
Upon completion of the article by van Vliet et al, the participant should be able to:
• State the prevalence of moderate or worse hearing impairment in this study’s cohort of patients with myotonic dystrophy type 2 (DM2)
• Discuss how results of audiometry and other testing aid in the localization of hearing loss in patients with DM2
• Describe the results of speech recognition testing in patients with DM2 in this study, and how this was associated with results of tone audiometry

Additional details will be posted as soon as they are available.